Difference between revisions of "Section 4: COVID-19: ICU delirium management:potential problems and solutions (from DOI: 10.1186/s13054-020-02882-x) (Q10754)"
Jump to navigation
Jump to search
(Created claim: named entity (P78): Propofol (chemical - MeSH descriptor) (Q11039), #quickstatements; #temporary_batch_1593005539138) |
(Created claim: named entity (P78): Pain (disease - MeSH descriptor) (Q11060), #quickstatements; #temporary_batch_1593005539138) |
||
| Property / named entity | |||
| + | |||
| Property / named entity: Pain (disease - MeSH descriptor) / rank | |||
| + | Normal rank | ||
Revision as of 13:32, 24 June 2020
Publication: "COVID-19: ICU delirium management during SARS-CoV-2 pandemic"published as Crit Care; 2020 04 28 ; 24 (1) 176; DOI: 10.1186/s13054-020-02882-x
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Section 4: COVID-19: ICU delirium management:potential problems and solutions (from DOI: 10.1186/s13054-020-02882-x)
|
Publication: "COVID-19: ICU delirium management during SARS-CoV-2 pandemic"published as Crit Care; 2020 04 28 ; 24 (1) 176; DOI: 10.1186/s13054-020-02882-x
|
Statements
0 references
0 references
